Literature DB >> 11697628

Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma.

W K Hofmann1, K Tsukasaki, N Takeuchi, S Takeuchi, H P Koeffler.   

Abstract

Central to many cancers is the aberrant expression of genes that regulate the cell cycle including the cyclin-dependent kinase inhibitors known as p15INK4b and p16INK4a, p14ARF and the retinoblastoma (RB) protein. We performed a detailed analysis of the methylation status of these genes by methylation specific polymerase chain reaction (MSP) in tumor cells of 35 adult T-cell leukemia/lymphoma (ATL) patients. We found in nine of 35 cases (26%) at least one gene methylated. The frequency of p15INK4b methylation was 7 of 35 (20%). The incidence of methylation of p14ARF and p16INK4a was two of 35 (6%) and one of 35 (3%), respectively. The RB gene was not found to be methylated in any of the ATL samples. The data indicate that inactivation of these cell cycle regulatory genes by hypermethylation is important in the development of ATL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697628     DOI: 10.3109/10428190109097731

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

Review 1.  Treatment of T-cell non-Hodgkin's lymphoma.

Authors:  Andrew M Evens; Ronald B Gartenhaus
Journal:  Curr Treat Options Oncol       Date:  2004-08

Review 2.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 3.  Human embryonic stem cells: mechanisms to escape replicative senescence?

Authors:  Xianmin Zeng
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 4.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

5.  Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.

Authors:  T Kameda; K Shide; H K Shimoda; T Hidaka; Y Kubuki; K Katayose; Y Taniguchi; M Sekine; A Kamiunntenn; K Maeda; K Nagata; T Matsunaga; K Shimoda
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

6.  Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis.

Authors:  Eisuke Uehara; Seisho Takeuchi; Yang Yang; Tetsuya Fukumoto; Yoshiko Matsuhashi; Takahiro Tamura; Masahide Matsushita; Masami Nagai; H Phillip Koeffler; Taizo Tasaka
Journal:  Oncol Lett       Date:  2011-09-13       Impact factor: 2.967

Review 7.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

8.  Targeting epigenetic regulators in the treatment of T-cell lymphoma.

Authors:  Nada Ahmed; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2020-01-22       Impact factor: 2.929

9.  Molecular hallmarks of adult T cell leukemia.

Authors:  Makoto Yamagishi; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2012-09-17       Impact factor: 5.640

Review 10.  HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma.

Authors:  Makoto Yamagishi; Dai Fujikawa; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Front Microbiol       Date:  2018-07-24       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.